Clinical Trial: A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naive Patients With Lower-Risk Myelodysplastic Syndromes in the United States

U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851065) titled 'A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naive Patients With Lower-Risk Myelodysplastic Syndromes in the United States' on Feb. 24.

Brief Summary: The purpose of this study is to understand real-world effectiveness of luspatercept treatment among erythropoiesis-stimulating agents -naive patients with lower-risk- myelodysplastic syndromes in the United States

Study Start Date: Aug. 22, 2024

Study Type: OBSERVATIONAL

Condition: Myelodysplastic Syndromes

Intervention: DRUG: Luspatercept

As per product lable

DRUG: Erythropoiesis-stimulating agents

As per product label...